| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/07/2006 | US20060277620 recombinant plant expression vector comprising a benzoate inducible promoter comprising a benzoate response element comprising a fragment operably linked to a promoter functional in a plant; agriculture, cost efficiency |
| 12/07/2006 | US20060277619 Method for identifying herbicidally active substances |
| 12/07/2006 | US20060277616 Method for cloning of the rat by nuclear transfer |
| 12/07/2006 | US20060277615 Method of determining xenograft responses |
| 12/07/2006 | US20060277614 Mammal prolactin variants |
| 12/07/2006 | US20060277613 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 12/07/2006 | US20060277610 Construction of knockdown animal by transferring double-stranded rna expression vector |
| 12/07/2006 | US20060276637 Antibodies |
| 12/07/2006 | US20060276636 Hyaluronate synthase gene and uses thereof |
| 12/07/2006 | US20060276635 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/07/2006 | US20060276633 Method for the mass production of immunoglobulin constant region |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276426 Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor |
| 12/07/2006 | US20060276425 Antisense oligomers and methods for inducing immune tolerance and immunosuppression |
| 12/07/2006 | US20060276424 Compositions and Methods for Treatment of Prostate and Other Cancers |
| 12/07/2006 | US20060276422 Useful for modulating the expression of genes, such as those genes associated with tumor mediated immunosuppression, immunopathology and/or proliferative diseases (e.g., cancer, restenosis, and polycystic kidney disease) |
| 12/07/2006 | US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent |
| 12/07/2006 | US20060276420 Generating cells for cell replacement therapy |
| 12/07/2006 | US20060276399 Peptide antagonists of zonulin and methods for use of the same |
| 12/07/2006 | US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein |
| 12/07/2006 | US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides |
| 12/07/2006 | US20060276382 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 12/07/2006 | US20060276377 Factor VII or VIIa Polypeptide Variants |
| 12/07/2006 | US20060276339 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 12/07/2006 | US20060275905 Gram positive bacterial mutants and methods of generating and using such mutants |
| 12/07/2006 | US20060275904 Method for introducing a gene into Labyrinthulomycota |
| 12/07/2006 | US20060275903 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/07/2006 | US20060275898 Compositions and Methods for Making Embryonic Stem Cells |
| 12/07/2006 | US20060275897 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen |
| 12/07/2006 | US20060275892 Reaction vessel, reaction apparatus and detection apparatus using the same, and method of manufacturing reaction vessel |
| 12/07/2006 | US20060275884 For reducing unwanted proteolysis during purification of a target protein; for improving protein folding, solubility, and stability when the protein is produced in vivo and in vitro |
| 12/07/2006 | US20060275881 Growing a recombinant microorganism that has at least one nucleic acid fragment encoding a phenylalanine hydroxylase polypeptide in the presence of a fermentable carbon substrate, especially glucose, to produce tyrosine |
| 12/07/2006 | US20060275872 Method for modifying transglutaminases from microorganisms |
| 12/07/2006 | US20060275871 encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs); drug screening to identify compounds which modulate the enzymatic activity of expression products |
| 12/07/2006 | US20060275869 Novel matrix metalloproteinases |
| 12/07/2006 | US20060275868 Fusion proteins comprising tumor necrosis factor receptor |
| 12/07/2006 | US20060275864 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/07/2006 | US20060275862 Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol B |
| 12/07/2006 | US20060275856 Method for analyzing cell free notch cleavage and method for drug screening |
| 12/07/2006 | US20060275833 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 12/07/2006 | US20060275830 Isolating nucleic acid encoding a plant polypeptide for use in generating disease resistant plants; obtain library, incubate with probe, recover clone, transform plant, propagate, evaluate for disease resistance |
| 12/07/2006 | US20060275822 Fluorescent indicator using fret |
| 12/07/2006 | US20060275807 Novel steroid 5alpha-reductase |
| 12/07/2006 | US20060275804 Enzymes having dehalogenase activity and methods of use thereof |
| 12/07/2006 | US20060275796 Canine herpesvirus thymidine kinase nucleic acid molecules |
| 12/07/2006 | US20060275791 Biological control of nanoparticle nucleation, shape and crystal phase |
| 12/07/2006 | US20060275789 Direct multiplex characterization of genomic DNA |
| 12/07/2006 | US20060275788 Method for rapid detection and identification of bioagents |
| 12/07/2006 | US20060275783 Gene markers for lung cancer |
| 12/07/2006 | US20060275774 Negative strand rna virus replicon |
| 12/07/2006 | US20060275773 Nucleic acid processing methods, kits and devices |
| 12/07/2006 | US20060275772 Nucleic acid probe of which end is labeled with a fluorescent dye, and in which fluorescence of the fluorescent dye decreases upon hybridization; mutation is detected on the basis of the result of the melting curve analysis |
| 12/07/2006 | US20060275769 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases |
| 12/07/2006 | US20060275763 Porcine polymorphisms and methods for detecting them |
| 12/07/2006 | US20060275762 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence processing method on comp |
| 12/07/2006 | US20060275760 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry |
| 12/07/2006 | US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/07/2006 | US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase |
| 12/07/2006 | US20060275744 Modified human embryonic stem cells and methods of use to treat neuron-associated disorders |
| 12/07/2006 | US20060275693 mixture of light to heat cnversion dyes dissolved in matrices, leuco dyes and activators; multiphase imaging material in which energy is absorbed by the light to heat cnversion dyes causes the reaction of an activator and leuco dyes |
| 12/07/2006 | US20060275338 Intravascular prosthesis containing an inhibitor of smooth muscle cell proliferation such as fibulin-5 (UP50) and a growth factor such as vascular endothelial growth factor (VEGF); stents; restenosis |
| 12/07/2006 | US20060275329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 12/07/2006 | US20060275323 Particles of HCV envelope proteins: use for vaccination |
| 12/07/2006 | US20060275322 producing an immune response to hepatitis C virus infection; activating cytotoxic t lymphocytes in presence of major histocompatibility complex |
| 12/07/2006 | US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter |
| 12/07/2006 | US20060275315 Nucleic acids and proteins from streptococcus groups a & b |
| 12/07/2006 | US20060275309 Peptide oligomers for use as hiv vaccines |
| 12/07/2006 | US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 12/07/2006 | US20060275302 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system |
| 12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
| 12/07/2006 | US20060275293 Splice variant of the human pituitary growth hormone |
| 12/07/2006 | US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275267 Nucleic acids encoding inactive variants of human telomerase |
| 12/07/2006 | US20060275266 Tripeptide of FcyRIIA |
| 12/07/2006 | US20060275264 Using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited; neurodegenerative diseases, Alzheimer's and Parkinson's disease; antiepileptic agents; drug delivery |
| 12/07/2006 | US20060275263 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy |
| 12/07/2006 | US20060275262 Conditionally replicating viruses and methods for cancer virotherapy |
| 12/07/2006 | US20060275261 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 12/07/2006 | US20060275259 Il-8-like proteins |
| 12/07/2006 | US20060275258 Interferon-alpha induced gene |
| 12/07/2006 | US20060275254 covalently linked to a drug that is a physiologically active polypeptide through a non-peptide linker; nonimmunogenic; extended serum half-life of a drug while maintaining the in vivo activity |
| 12/07/2006 | DE102006020463A1 Procedure for partial removal of nucleic acid from a liquid, which is obtained during lysis of microorganism, comprises binding selective adsorbing component that freely floats in the liquid after pre-set incubation time |
| 12/07/2006 | DE102005025656A1 Promotor zur epidermisspezifischen, pathogeninduzierbaren Transgenexpression in Pflanzen Promoter for the epidermis, pathogen transgene expression in plants |
| 12/07/2006 | DE10161738B4 Fusionsproteine gegen T-Zell-Tumore Fusion proteins against T-cell tumors |
| 12/07/2006 | DE10127247B4 Vorrichtung und Verfahren zur elektrischen Behandlung suspendierter biologischer Partikel Apparatus and method for electrical treatment suspended biological particles |
| 12/07/2006 | CA2611056A1 Method of targeted gene delivery using viral vectors |
| 12/07/2006 | CA2610786A1 High affinity melan-a t cell receptors |
| 12/07/2006 | CA2610780A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein |
| 12/07/2006 | CA2610710A1 Peptide nucleic acid probes for analysis of microorganisms |
| 12/07/2006 | CA2610702A1 Targeting cells with altered microrna expression |
| 12/07/2006 | CA2610644A1 Rnai for control of insects and arachnids |
| 12/07/2006 | CA2610413A1 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 12/07/2006 | CA2610391A1 A method for optimized production of a recombinant form of tissue plasminogen activator |
| 12/07/2006 | CA2610271A1 Autoactivated resistance protein |
| 12/07/2006 | CA2610267A1 Method of inhibiting intimal hyperplasia |
| 12/07/2006 | CA2610234A1 Antibodies directed to cd20 and uses thereof |
| 12/07/2006 | CA2610164A1 Novel glutamic acid decarboxylase (gad) chimera and methods of use |
| 12/07/2006 | CA2610087A1 Promoter for epidermis-specific pathogen-inducible transgenic expression in plants |
| 12/07/2006 | CA2609910A1 Methods and compositions for determining resistance of hiv-1 to protease inhibitors |